✦ LIBER ✦

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

✍ Scribed by Paul W. Armstrong; Peter X. Adams; Hussein R. Al-Khalidi; Christian Hamm; David Holmes; William O'Neill; Thomas G. Todaro; Alec Vahanian; Frans Van de Werf; Christopher B. Granger

Book ID: 116190021
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 179 KB
Volume: 149
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2004.12.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pexelizumab fails to inhibit assembly of

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Catherine Martel; Christopher B. Granger; Marta Ghitescu; Amanda Stebbins; Annik 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Variations in practice and outcomes in p

Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial

✍ Rajendra H. Mehta; Padma Kaul; Renato D. Lopes; Manesh R. Patel; Yinggan Zheng; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Is visual interpretation of coronary epi

Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Osama Alhadramy; Cynthia M. Westerhout; Sorin J. Brener; Christopher B. Granger; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 320 KB

A unicenter, randomized, double-blind, p

A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty: The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: Study design and rationale

✍ Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Martín J. Garcia-Gonzalez; Ju 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Predictors of Reperfusion Delay in Patie

Predictors of Reperfusion Delay in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention from the HORIZONS-AMI Trial

✍ James C. Blankenship; Kimberly A. Skelding; Thomas D. Scott; Peter B. Berger; He 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 198 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)

✍ Ik-Kyung Jang; Neil J. Weissman; Michael H. Picard; Michael R. Zile; Veronica Pe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 264 KB